Simmons emerges as major sponsor of Atlanta charity golf tournament

Announcement follows major TGen success in treating pancreatic cancer

ATLANTA - Sept. 24, 2013 - Following on the heels of a major scientific success for the Translational Genomics Research Institute (TGen), Simmons Bedding Company (Simmons), one of the nation's leading mattress companies, announced today they will be a major sponsor of Howard Young's 2013 Atlanta Golf Classic, supporting pancreatic cancer research at TGen.

Atlanta-based Simmons will co-sponsor the charity golf tournament, which expects to attract 120 golfers Oct. 7 just north of Atlanta at the Capital City Crabapple Golf Club in Alpharetta, Ga.

The 4th annual tournament, which each year has raised more than $100,000 for TGen's pancreatic cancer research, will be co-hosted by the Seena Magowitz Foundation, John Morley, Tom Vitale and Howard Young, a pancreatic cancer survivor who chairs the TGen Foundation's National Pancreatic Cancer Committee.

"The addition of Simmons as a major sponsor is a significant milestone in the brief history of this highly successful fundraising tournament," said Young, an Atlanta businessman who has survived this most aggressive of all cancers for more than a decade. Only 1 in 4 pancreatic cancer patients survive more than a year, and fewer than 6 percent survive more than 5 years. "I owe my life to TGen, and especially to TGen Physician-In-Chief Dr. Daniel Von Hoff, one of the nation's leading experts on this disease."

Simmons President Tony Smith said his company, devoted to innovation and cutting-edge technology, is honored to contribute to TGen's groundbreaking research.

"As an Atlanta-based company, Simmons is happy to partner with fellow Atlantan Howard Young in this most worthwhile cause, which can help bring hope and, perhaps someday a cure, to tens of thousands of cancer patients stricken each year with this deadly disease," Smith said.

Pancreatic cancer is the nation's fourth leading cause of cancer-related death, responsible this year for an estimated 45,000 new cases, and more than 38,000 deaths. There is no method of early detection, so pancreatic cancer patients often are not diagnosed until their cancer is in its advanced stages.

On Sept. 6, the U.S. Food and Drug Administration approved Abraxane for patients with advanced pancreatic cancer, following 7 years of rigorous clinical trials overseen by a partnership of Scottsdale Healthcare and TGen. Part of this research, called the Seena Trials, was funded by the Seena Magowitz Foundation.

Abraxane, the brand name for nab-paclitaxel, was approved for use in combination with gemcitabine, the previous standard drug therapy, following a large scale international clinical trial headed by TGen's Dr. Von Hoff, who also serves as Chief Scientific Officer at Scottsdale Healthcare's Virginia G. Piper Cancer Center Clinical Trials, a partnership of Scottsdale Healthcare and TGen.

"The FDA's approval of Abraxane for treatment of pancreatic cancer is a huge step forward in our efforts to help conquer this disease that affects so many thousands of patients across the country," said Roger Magowitz, Presidentof the Seena Magowitz Foundation, which he founded in honor of his mother, Seena, whodied of pancreatic cancer in 2001.

"The addition of Simmons as a lead sponsor of the Atlanta Golf Classic positions the tournament for a significant expansion in the future," Magowitz said.

The Atlanta Golf Classic kicks off the fall fundraising drive of the Seena Magowitz Foundation, which supports innovative pancreatic cancer research and clinical trials conducted by TGen, a Phoenix-based world-class non-profit biomedical research center.

On Dec. 7, the Magowitz Foundation will host its 11th annual Seena Magowitz Golf Classic, returning for the third year to the storied Arizona Biltmore Resort and Spa in Phoenix. Net proceeds from last year's Phoenix and Atlanta tournaments collectively raised more than $500,000 for TGen's international initiative to eradicate pancreatic cancer.

The Capital City Crabapple Golf Club is located at 13802 New Providence Road in Alpharetta, Ga. The Atlanta Golf Classic is Oct. 7, with registration starting at 8 a.m., a shotgun start at 9:30 a.m., followed by an awards luncheon at 2:30 p.m., including a raffle and live auction.

Donations are still being accepted, and non-golfers are invited to attend the awards luncheon. Please contact Tournament Director Liz McBeth at [email protected] or (757) 773-3622.

For more information, visit: Or contact Roger E. Magowitz at [email protected] or 602-524-7636.

# # #

About the Seena Magowitz Foundation

The Seena Magowitz Foundation is a 501(c)(3) non-profit organization committed to advancing the awareness and eventual prevention and cure of pancreatic cancer. The Foundation is dedicated to funding top medical institutions on the leading edge of translational pancreatic cancer research committed to diagnosis, the advancement of life-extending treatment options and the ultimate goal of eradicating this deadly killer. For more information, visit:


About Simmons Bedding Company
Atlanta-based Simmons Bedding Company is one of the world's largest mattress producers and the maker of Beautyrest®. Simmons manufactures and markets a broad range of products including Beautyrest®, Beautyrest TruEnergy™, Beautyrest Black®, ComforPedic® from Beautyrest®, and BeautySleep®. Simmons Bedding operates 19 conventional bedding manufacturing facilities across the United States, Canada and Puerto Rico. Simmons Bedding also serves as a key supplier of beds to many of the world's leading hotel groups and resort properties. Simmons Bedding is committed to developing superior mattresses and promoting a higher-quality sleep, helping ensure consumers around the world are Living Life Fully Charged™. For more information, visit:, or follow us on Facebook, Twitter and YouTube.

Press Contact:

Christina Schrempp

(404) 835-4521
[email protected]


About TGen
Translational Genomics Research Institute (TGen) is a Phoenix, Arizona-based non-profit organization dedicated to conducting groundbreaking research with life changing results. TGen is focused on helping patients with cancer, neurological disorders and diabetes, through cutting edge translational research (the process of rapidly moving research towards patient benefit). TGen physicians and scientists work to unravel the genetic components of both common and rare complex diseases in adults and children. Working with collaborators in the scientific and medical communities literally worldwide, TGen makes a substantial contribution to help our patients through efficiency and effectiveness of the translational process. For more information,

Press Contact:
Steve Yozwiak
TGen Senior Science Writer
[email protected]

Media Contact

RSS Feed